文献速递耳科与耳神经小儿耳鼻咽喉

前庭导水管扩大伴SLC26A4零个或一个突变等位基因相关的听力损失

Hearing loss associated with enlarged vestibular aqueduct and zero or one mutant allele of SLC26A4.
PubMed 文献 · Laryngoscope · 2016-11-15

该前瞻性队列研究纳入1998至2015年在美国国立卫生研究院临床中心招募的127例前庭导水管扩大(EVA)患者,中位年龄8岁(范围0-59岁)。携带SLC26A4零个或一个突变等位基因的EVA耳平均听阈低于携带两个突变等位基因的EVA耳(62.6和52.9 dB HL vs 88.1 dB HL,P<.01),且听力波动患病率无差异,人工耳蜗植入患病率更低。

要点

  • EVA耳携带SLC26A4零个或一个突变等位基因时,平均0.5/1/2/4-kHz纯音听阈分别为62.6和52.9 dB HL,低于两个突变等位基因耳的88.1 dB HL(P<.01)。
  • 听力损失自然史与突变等位基因数量无关(P=.94)。
  • 零个、一个和两个突变等位基因组人工耳蜗植入患病率分别为12%(9/76)、13%(2/15)和38%(12/32)(P=.00833)。

核心结论

  • 携带SLC26A4零个或一个突变等位基因的EVA耳听力损失较轻,听力波动患病率无差异,人工耳蜗植入患病率低于携带两个突变等位基因的EVA耳。

研究设计与样本

  • 前瞻性队列研究,于1998至2015年在美国国立卫生研究院临床中心招募受试者,共纳入127例至少一只耳有EVA的个体,中位年龄8岁(范围0-59岁)。

主要发现

  • 携带SLC26A4零个和一個突变等位基因的EVA耳平均0.5/1/2/4-kHz纯音听阈分别为62.6和52.9 dB HL,两个突变等位基因的EVA耳为88.1 dB HL(P<.01)。
  • 该关联独立于年龄、性别或EVA侧别(P<.001)。
  • 听力损失自然史与突变等位基因数量无关(P=.94)。
  • 零个、一个和两个突变等位基因组人工耳蜗植入患病率分别为12%(9/76)、13%(2/15)和38%(12/32)(P=.00833)。
  • 人工耳蜗植入与突变等位基因数量的关联不独立(P=.534),反映其与首次听力图时年龄(P=.003)或听力损失严重程度(P=.000)的相关性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: To characterize the severity and natural history of hearing loss, and the prevalence of having a cochlear implant in a maturing cohort of individuals with enlarged vestibular aqueduct (EVA) and zero or one mutant allele of SLC26A4. STUDY DESIGN: Prospective cohort study of subjects ascertained between 1998 and 2015 at the National Institutes of Health Clinical Center. METHODS: Study subjects were 127 individuals (median age, 8 years; range, 0-59 years) with EVA in at least one ear. RESULTS: Ears with EVA and zero or one mutant allele of SLC26A4 had mean 0.5/1/2/4-kHz pure-tone averages of 62.6 and 52.9 dB HL, respectively, in contrast to EVA ears with two mutant alleles of SLC26A4 (88.1 dB HL; P < .01). This association was independent of age, sex, or side of EVA (P < .001). Natural history of hearing loss was not associated with number of mutant alleles (P = .94). The prevalence of having a cochlear implant was nine (12%) of 76, two (13%) of 15, and 12 (38%) of 32 subjects with zero, one, and two mutant alleles, respectively (P = .00833). This association was not independent (P = .534) but reflected underlying correlations with age at time of first audiogram (P = .003) or severity of hearing loss (P = .000). CONCLUSIONS: Ears with EVA and zero or one mutant allele of SLC26A4 have less severe hearing loss, no difference in prevalence of fluctuation, and a lower prevalence of cochlear implantation in comparison to ears with two mutant alleles of SLC26A4. LEVEL OF EVIDENCE: NA Laryngoscope, 127:E238-E243, 2017.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Rose J, Muskett JA, King KA, et al. Hearing loss associated with enlarged vestibular aqueduct and zero or one mutant allele of SLC26A4. Laryngoscope. 2016. PMID: 27859305. doi:10.1002/lary.26418

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。